Global Unresectable Hepatocellular Carcinoma Market Report By Treatment (Chemotherapy, Molecularly Targeted Therapy, Immunotherapy), By End-Use (Hospitals, Specialty Clinics, Cancer Centers, Research institutes)And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2020-2027

ID:VMR11212416
April 2021
Report Formats:
The global demand for Unresectable Hepatocellular Carcinoma Market is presumed to reach the valuation of nearly USD XX MN by 2026 from USD XX MN in 2019 with a CAGR of XX% under the study period of 2020 - 2026.
 
Hepatocellular carcinoma is a type of primary liver cancer. It is highly angiogenic solid tumour characterized molecularly by cell-cycle dysregulation, aberrant angiogenesis, and evasion of apoptosis. It occurs most often in people with chronic liver diseases.  The risk is higher in people with long term liver diseases, in people who drink large amounts of alcohol, and one who has an accumulation of fat in the liver. An unresectable hepatocellular carcinoma cannot be treated with surgeries, the treatment includes drug therapy, immunotherapy, radiotherapy, and destroying cancer with heat or cold.
 
Market Dynamics
 
Hepatocellular carcinoma is one of the most prevalent worldwide. It is associated with a very low 5-year survival rate. Very few patients with HCC qualify for surgical resection or liver transplantation, as more than half of all HCCs are diagnosed at an advanced stage of the disease. Asia contributes a particularly large prevalence of the global hepatocellular carcinoma (HCC), accounting for nearly two-thirds of the newly diagnosed. The majority of HCC patients are diagnosed at unresectable stages. Intraarterial therapy (IAT), specifically transarterial chemoembolization, is considered the standard of care in patients with unresectable HCC. Other recent options are sorafenib, regorafenib, nivolumab, lenvatinib, pembrolizumab, cabozantinib, and ramucirumab. However, there is no evidence that currently used anatomic response criteria are adequate for overall survival because tumour shrinkage is rarely observed in patients with unresectable HCC after IAT.
 
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
 
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of unresectable hepatocellular carcinoma.
 
Market Segmentation
 
The entire unresectable hepatocellular carcinoma market has been sub-categorized into treatment and end-user. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
 
By Treatment
  • Chemotherapy
  • Molecularly Targeted Therapy
  • Immunotherapy
 
By End-Use
  • Hospitals
  • Specialty Clinics
  • Cancer Centers
  • Research institutes
 
Regional Analysis
 
This section covers regional segmentation which accentuates on current and future demand for unresectable hepatocellular carcinoma market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
 
Global Unresectable Hepatocellular Carcinoma Market Share by Region (Representative Graph)
 
Global Unresectable Hepatocellular Carcinoma Market Share
 
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the unresectable hepatocellular carcinoma market include Eisai Co., Ltd, Bayer AG, Bristol- Myers Squibb Company, Sumitomo Dainippon Pharma Co., Ltd, Glaxosmithkline Plc. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
                                            
METHODOLOGY:
 
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources,  Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
 
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Unresectable Hepatocellular Carcinoma Market
       2.2. Global Unresectable Hepatocellular Carcinoma Market Snapshot
 
3 . UNRESECTABLE HEPATOCELLULAR CARCINOMA – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Unresectable Hepatocellular Carcinoma Market
       3.3. Market Restraints of Unresectable Hepatocellular Carcinoma Market
       3.4. Opportunities of Unresectable Hepatocellular Carcinoma Market
       3.5. Trends of Unresectable Hepatocellular Carcinoma Market
       3.6. Porter’s Five Force Analysis of Unresectable Hepatocellular Carcinoma Market
       3.7. Unresectable Hepatocellular Carcinoma Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Treatment
           3.7.2 Market Attractive Analysis by End-Use
           3.7.3 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Unresectable Hepatocellular Carcinoma Value Chain Analysis
       4.2. Unresectable Hepatocellular Carcinoma Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Unresectable Hepatocellular Carcinoma Raw Material Manufactures List
           4.2.3. Price Trend of Unresectable Hepatocellular Carcinoma Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak on Unresectable Hepatocellular Carcinoma Market
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Unresectable Hepatocellular Carcinoma Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Unresectable Hepatocellular Carcinoma Market Size in 2020, by Scenario
       5.5. COVID-19: Micro and Macro Factor Analysis on Unresectable Hepatocellular Carcinoma Market
 
6 . GLOBAL UNRESECTABLE HEPATOCELLULAR CARCINOMA MARKET ANALYSIS BY TREATMENT
       6.1 Overview by Treatment
       6.2 Global Unresectable Hepatocellular Carcinoma Market Analysis by Treatment
       6.3 Market Analysis of Chemotherapy by Regions
       6.4 Market Analysis of Molecularly Targeted Therapy by Regions
       6.6 Market Analysis of Immunotherapy by Regions
 
7 . GLOBAL UNRESECTABLE HEPATOCELLULAR CARCINOMA MARKET ANALYSIS BY END-USE
       7.1 Overview by End-Use
       7.2 Global Unresectable Hepatocellular Carcinoma Market Analysis by End-Use
       7.3 Market Analysis of Hospitals by Regions
       7.4 Market Analysis of Specialty Clinics by Regions
       7.5 Market Analysis of Cancer Centers by Regions
       7.6 Market Analysis of Research Institutes by Regions
 
8 . GLOBAL UNRESECTABLE HEPATOCELLULAR CARCINOMA MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America
           8.3.1. Overview
           8.3.2. North America Unresectable Hepatocellular Carcinoma Market Estimate by Market Segment
           8.3.3. North America Unresectable Hepatocellular Carcinoma Market Estimate by Country
           8.3.4. United State
           8.3.5. Rest of North America
       8.4. Europe
           8.4.1. Overview
           8.4.2. Europe Unresectable Hepatocellular Carcinoma Market Estimate by Market Segment
           8.4.3. Europe Unresectable Hepatocellular Carcinoma Market Estimate by Country
           8.4.4. United Kingdom
           8.4.5. France
           8.4.6. Germany
           8.4.8 Rest of Europe
       8.5. Asia Pacific
           8.5.1. Overview
           8.5.2. Asia Pacific Unresectable Hepatocellular Carcinoma Market Estimate by Market Segment
           8.5.3. Asia Pacific Unresectable Hepatocellular Carcinoma Market Estimate by Country
           8.5.4. China
           8.5.5. Japan
           8.5.6. India
           8.5.8. Rest of Asia Pacific
       8.6. Latin America
           8.6.1. Overview
           8.6.2. Latin America Unresectable Hepatocellular Carcinoma Market Estimate by Market Segment
           8.6.3. Latin America Unresectable Hepatocellular Carcinoma Market Estimate by Country
           8.6.4. Brazil
           8.6.5. Rest of Latin America
       8.8. Middle East & Africa
           8.8.1. Overview
           8.8.2. Middle East & Africa Unresectable Hepatocellular Carcinoma Market Estimate by Market Segment
           8.8.3. Middle East & Africa Unresectable Hepatocellular Carcinoma Market Estimate by Country
           8.8.4. Middle East
           8.8.5. Africa
 
9 . COMPETITIVE LANDSCAPE OF THE UNRESECTABLE HEPATOCELLULAR CARCINOMA COMPANIES
       9.1. Unresectable Hepatocellular Carcinoma Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments
 
10 . COMPANY PROFILES OF UNRESECTABLE HEPATOCELLULAR CARCINOMA INDUSTRY
       10.1. Company Share Analysis
       10.2. Market Concentration Rate
       10.3. Eisai Co., Ltd.
           10.3.1. Company Overview
           10.3.2. Financials
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. Bayer AG
           10.4.1. Company Overview
           10.4.2. Financials
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. Bristol- Myers Squibb Company
           10.5.1. Company Overview
           10.5.2. Financials
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. Sumitomo Dainippon Pharma Co., Ltd.
           10.6.1. Company Overview
           10.6.2. Financials
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. Glaxosmithkline Plc
           10.7.1. Company Overview
           10.7.2. Financials
           10.7.3. Products
           10.7.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global Unresectable Hepatocellular Carcinoma Market Snapshot
  • Drivers of The Global Unresectable Hepatocellular Carcinoma Market Impact Analysis
  • Restraints of The Global Unresectable Hepatocellular Carcinoma Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Unresectable Hepatocellular Carcinoma Market: Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Unresectable Hepatocellular Carcinoma Market Size In 2020, By Scenario
  • COVID-19: Micro and Macro Factor Analysis on Unresectable Hepatocellular Carcinoma Market
  • Global Unresectable Hepatocellular Carcinoma Market Analysis by Treatment (USD MN)
  • Global Unresectable Hepatocellular Carcinoma Market Analysis in Chemotherapy by Geography (USD MN)
  • Global Unresectable Hepatocellular Carcinoma Market Analysis in Molecularly Targeted Therapy by Geography (USD MN)
  • Global Unresectable Hepatocellular Carcinoma Market Analysis in Immunotherapy by Geography (USD MN)
  • Global Unresectable Hepatocellular Carcinoma Market Analysis by End-Use (USD MN)
  • Global Unresectable Hepatocellular Carcinoma Market Analysis in Hospitals by Geography (USD MN)
  • Global Unresectable Hepatocellular Carcinoma Market Analysis in Specialty Clinics by Geography (USD MN)
  • Global Unresectable Hepatocellular Carcinoma Market Analysis in Cancer Centers by Geography (USD MN)
  • Global Unresectable Hepatocellular Carcinoma Market Analysis in Research Institutes by Geography (USD MN)
  • Global Unresectable Hepatocellular Carcinoma Market by Geography (USD MN)
  • North America Unresectable Hepatocellular Carcinoma Market Analysis by Treatment (USD MN)
  • North America Unresectable Hepatocellular Carcinoma Market Estimate by End-Use (USD MN)
  • North America Unresectable Hepatocellular Carcinoma Market Estimate by Country (USD MN)
  • United State Unresectable Hepatocellular Carcinoma Market Analysis by Treatment (USD MN)
  • United State Unresectable Hepatocellular Carcinoma Market Estimate by End-Use (USD MN)
  • Rest of North America Unresectable Hepatocellular Carcinoma Market Analysis by Treatment (USD MN)
  • Rest of North America Unresectable Hepatocellular Carcinoma Market Estimate by End-Use (USD MN)
  • Europe Unresectable Hepatocellular Carcinoma Market Analysis by Treatment (USD MN)
  • Europe Unresectable Hepatocellular Carcinoma Market Estimate by End-Use (USD MN)
  • United Kingdom Unresectable Hepatocellular Carcinoma Market Analysis by Treatment (USD MN)
  • United Kingdom Unresectable Hepatocellular Carcinoma Market Estimate by End-Use (USD MN)
  • France Unresectable Hepatocellular Carcinoma Market Analysis by Treatment (USD MN)
  • France Unresectable Hepatocellular Carcinoma Market Estimate by End-Use (USD MN)
  • Germany Unresectable Hepatocellular Carcinoma Market Analysis by Treatment (USD MN)
  • Germany Unresectable Hepatocellular Carcinoma Market Estimate by End-Use (USD MN)
  • Rest of Europe Unresectable Hepatocellular Carcinoma Market Analysis by Treatment (USD MN)
  • Rest of Europe Unresectable Hepatocellular Carcinoma Market Estimate by End-Use (USD MN)
  • Asia Pacific Unresectable Hepatocellular Carcinoma Market Analysis by Treatment (USD MN)
  • Asia Pacific Unresectable Hepatocellular Carcinoma Market Estimate by End-Use (USD MN)
  • Asia Pacific Unresectable Hepatocellular Carcinoma Market Estimate by Country (USD MN)
  • China Unresectable Hepatocellular Carcinoma Market Analysis by Treatment (USD MN)
  • China Unresectable Hepatocellular Carcinoma Market Estimate by End-Use (USD MN)
  • Japan Unresectable Hepatocellular Carcinoma Market Analysis by Treatment (USD MN)
  • Japan Unresectable Hepatocellular Carcinoma Market Estimate by End-Use (USD MN)
  • India Unresectable Hepatocellular Carcinoma Market Analysis by Treatment (USD MN)
  • India Unresectable Hepatocellular Carcinoma Market Estimate by End-Use (USD MN)
  • Rest of Asia Pacific Unresectable Hepatocellular Carcinoma Market Analysis by Treatment (USD MN)
  • Rest of Asia Pacific Unresectable Hepatocellular Carcinoma Market Estimate by End-Use (USD MN)
  • Latin America Unresectable Hepatocellular Carcinoma Market Analysis by Treatment (USD MN)
  • Latin America Unresectable Hepatocellular Carcinoma Market Estimate by End-Use (USD MN)
  • Latin America Unresectable Hepatocellular Carcinoma Market Estimate by Country (USD MN)
  • Brazil Unresectable Hepatocellular Carcinoma Market Analysis by Treatment (USD MN)
  • Brazil Unresectable Hepatocellular Carcinoma Market Estimate by End-Use (USD MN)
  • Rest of Latin America Unresectable Hepatocellular Carcinoma Market Analysis by Treatment (USD MN)
  • Rest of Latin America Unresectable Hepatocellular Carcinoma Market Estimate by End-Use (USD MN)
  • Middle East & Africa Unresectable Hepatocellular Carcinoma Market Analysis by Treatment (USD MN)
  • Middle East & Africa Unresectable Hepatocellular Carcinoma Market Estimate by End-Use (USD MN)
  • Middle East & Africa Unresectable Hepatocellular Carcinoma Market Estimate by Country (USD MN)
  • Middle East Unresectable Hepatocellular Carcinoma Market Analysis by Treatment (USD MN)
  • Middle East Unresectable Hepatocellular Carcinoma Market Estimate by End-Use (USD MN)
  • Africa Unresectable Hepatocellular Carcinoma Market Analysis by Treatment (USD MN)
  • Africa Unresectable Hepatocellular Carcinoma Market Estimate by End-Use (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis, 2019
 
LIST OF FIGURES
 
  • Research Scope of Unresectable Hepatocellular Carcinoma Report
  • Market Research Process
  • Market Research Methodology
  • Global Unresectable Hepatocellular Carcinoma Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Treatment
  • Market Attractiveness Analysis by End-Use
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Unresectable Hepatocellular Carcinoma Market Analysis by Treatment (USD MN)
  • Global Unresectable Hepatocellular Carcinoma Market Analysis in Chemotherapy by Geography (USD MN)
  • Global Unresectable Hepatocellular Carcinoma Market Analysis in Molecularly Targeted Therapy by Geography (USD MN)
  • Global Unresectable Hepatocellular Carcinoma Market Analysis in Immunotherapy by Geography (USD MN)
  • Global Unresectable Hepatocellular Carcinoma Market Analysis by End-Use (USD MN)
  • Global Unresectable Hepatocellular Carcinoma Market Analysis in Hospitals by Geography (USD MN)
  • Global Unresectable Hepatocellular Carcinoma Market Analysis in Specialty Clinics by Geography (USD MN)
  • Global Unresectable Hepatocellular Carcinoma Market Analysis in Cancer Centers by Geography (USD MN)
  • Global Unresectable Hepatocellular Carcinoma Market Analysis in Research Institutes by Geography (USD MN)
  • Latin America Unresectable Hepatocellular Carcinoma Market by Revenue
  • Middle East & Africa Unresectable Hepatocellular Carcinoma Market by Revenue
  • Recent Development in Unresectable Hepatocellular Carcinoma Industry
  • Company Market Share Analysis, 2019
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials